Enanta Pharmaceuticals amends equity plan, adds 1.05M shares for issuance

ENANTA PHARMACEUTICALS INC

Stockholders approved amendment to 2019 Equity Incentive Plan at March 3, 2022 annual meeting.
Increase of 1,050,000 shares of common stock reserved for issuance under the plan.
Plan as amended filed as Exhibit 10.1.

item 5.02 item 9.01

ENANTA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0000950170-22-003221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.